Japan Blood Glucose Monitoring Market Introduction and Overview
According to SPER Market Research, the Japan Blood Glucose Monitoring Market is estimated to reach USD 1.6 billion by 2033 with a CAGR 7.25%.
The report includes an in-depth analysis of the Japan Blood Glucose Monitoring Market, including market size and trends, product mix, distribution channels, and supplier analysis. The practice of routinely determining the amount of glucose in the blood is known as blood glucose monitoring. For people with diabetes to effectively manage their illness, this monitoring is necessary. By determining their blood glucose levels, people can make well-informed choices regarding their medicine, nutrition, and activity to maintain a healthy blood sugar range. A variety of equipment, such as wearable technology, continuous glucose monitoring systems, and glucose meters, can be used to measure blood glucose.
- In June 2023, Kakao Healthcare plans to launch a Dexcom-powered diabetes management program. This partnership makes use of Dexcom's cutting-edge continuous glucose monitoring (CGM) devices, specifically the Dexcom G6 and G7, as well as Kakao Healthcare's proficiency in AI and software technologies. It is important to note that Dexcom is presently working to get the Ministry of Food and Drug Safety to approve these devices.
- In May 2022, Terumo declares that the Dexcom G6 CGM System's indication has been modified in Japan. With the addition of this additional indication, the Dexcom G6 CGM System will be the only one available in Japan that can be used primarily for managing blood glucose levels on a daily basis without the need for a blood glucose meter.
Market Opportunities and Challenges
Opportunities: The market has grown as a result of the Japanese government's aggressive promotion of diabetes treatment and prevention initiatives. These initiatives frequently stress the value of routine blood glucose checks, which raises awareness and increases demand for blood glucose monitoring equipment. Additionally, more accurate and user-friendly blood glucose sensors have been developed as a result of technological improvements. These gadgets are more convenient and enticing to people with diabetes since they frequently have features like wireless networking, smartphone integration, and continuous glucose monitoring. The market's expansion has also been aided by the availability of such cutting-edge equipment.
Challenges: The fierce rivalry between local and foreign producers is a defining feature of the Japanese glucose monitoring devices market. This competitive environment presents a number of difficulties for businesses looking to enter or grow their market share. International players provide cutting-edge technologies and worldwide experience, while domestic manufacturers profit from well-established distribution networks and high brand awareness. Differentiation is one of the main obstacles in this competitive economy. To gain market share, manufacturers must constantly develop and distinguish their products. Creating glucose monitoring devices with cutting-edge capabilities like real-time data processing, mobile application integration, and improved user interface design is part of this. However, the introduction of new technology necessitates large research and development expenditures, which can be costly, especially for smaller businesses.
Market Competitive Landscape
The market for blood glucose monitoring is very fragmented, and there aren't many significant manufacturers. Major companies like Dexcom, Medtronics, Abbott, and Senseonics control a large portion of the market for CGM devices. More generic companies like Roche, LifeScan, Arkray, Ascensia, and others are present in the BGM device industry.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Type, By Component |
| Regions covered | Kanto Region, Kniki Region, Central/Chubu Region, Kyushu-Okinawa Region, Chugoku Region Shikoku Region |
| Companies Covered | Abbott Diabetes Care, Roche Holding AG, LifeScan, Dexcom Inc, Medtronic PLC, Arkray Inc, Ascensia Diabetes Care, Agamatrix Inc, Bionime Corporation, Acon Laboratories Inc. |
COVID-19 Impact on Japan Blood Glucose Monitoring Market
The COVID-19 pandemic has had a huge impact on Japan's blood glucose monitoring market. The epidemic increased the significance of remote monitoring while reducing in-person healthcare appointments. Individuals with diabetes, who are thought to be at a higher risk of serious COVID-19 problems, have increasingly turned to telehealth options and home-based blood glucose monitoring to safely manage their illness. The pandemic also highlighted vulnerabilities in healthcare systems, emphasizing the importance of effective diabetes treatment measures. Governments and healthcare organizations worked to improve diabetes care infrastructure, including access to blood glucose monitoring equipment, in order to lower the risk of complications and improve overall patient outcomes.
Type Insights
Continuous glucose monitoring has the highest CAGR in Japan's blood glucose monitoring market.
Diabetes is a chronic, complicated condition that can lead to myocardial infarction, stroke, renal disease, blindness, and neuropathy. To prevent deterioration and the development of problems, patients must manage their blood sugar levels on a daily basis. Recent years have seen the development of apps for real-time continuous glucose monitoring (CGM) on smartphones and other devices connected to CGM systems; these apps are also in use in Japan. Patients' blood glucose management is improved by using CGM apps as opposed to standard retrospective CGM, which should help delay the course of Type 2 diabetes mellitus (DM) and avoid problems.
Key Target Audience
- Diabetes Patients
- Hospitals and Clinics
- Healthcare Professionals (Endocrinologists, Diabetologists)
- Home Care Providers
- Pharmacies and Retailers
- Diabetes Management Centers
- Medical Device Manufacturers and Distributors
- Government and Regulatory Bodies
- Insurance Companies
Our in-depth analysis of the Japan Blood Glucose Monitoring Market includes the following segments:
| By Type: | Self-Monitoring Blood GlucoseContinuous Glucose Monitoring |
| By Component: | Glucometer DevicesTest StripsLancetsSensorsDurables |
| By Region: | Kanto RegionKinki RegionCentral/ Chubu RegionKyushu-Okinawa RegionChugoku RegionShikoku Region |
Key Topics Covered in the Report
- Japan Blood Glucose Monitoring Market Size (FY’2024-FY’2033)
- Overview of Japan Blood Glucose Monitoring Market
- Segmentation of Japan Blood Glucose Monitoring Market By Type (Self-Monitoring Blood Glucose, And Continuous Glucose Monitoring)
- Segmentation of Japan Blood Glucose Monitoring Market By Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables)
- Statistical Snap of Japan Blood Glucose Monitoring Market
- Expansion Analysis of Japan Blood Glucose Monitoring Market
- Problems and Obstacles in Japan Blood Glucose Monitoring Market
- Competitive Landscape in the Japan Blood Glucose Monitoring Market
- Impact of COVID-19 and Demonetization on Japan Blood Glucose Monitoring Market
- Details on Current Investment in Japan Blood Glucose Monitoring Market
- Competitive Analysis of Japan Blood Glucose Monitoring Market
- Prominent Players in the Japan Blood Glucose Monitoring Market
- SWOT Analysis of Japan Blood Glucose Monitoring Market
- Japan Blood Glucose Monitoring Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Japan Blood Glucose Monitoring Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Japan Blood Glucose Monitoring Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Japan Blood Glucose Monitoring Market
7. Japan Blood Glucose Monitoring Market, By Type (USD Million) 2020-2033
7.1. Japan Blood Glucose Monitoring Market Size, Share and Forecast, By Type, 2020-2026
7.2. Japan Blood Glucose Monitoring Market Size, Share and Forecast, By Type, 2027-2033
7.3. Self-Monitoring Blood Glucose
7.4. Continuous Glucose Monitoring
8. Japan Blood Glucose Monitoring Market, By Component (USD Million) 2020-2033
8.1. Japan Blood Glucose Monitoring Market Size, Share and Forecast, By Component, 2020-2026
8.2. Japan Blood Glucose Monitoring Market Size, Share and Forecast, By Component, 2027-2033
8.3. Glucometer Devices
8.4. Test Strips
8.5. Lancets
8.6. Sensors
8.7. Durables
9. Japan Blood Glucose Monitoring Market Forecast, 2020-2033 (USD Million)
9.1. Japan Blood Glucose Monitoring Market Size and Market Share
10. Japan Blood Glucose Monitoring Market, By Region, 2020-2033 (USD Million)
10.1. Japan Blood Glucose Monitoring Market Size and Market Share By Region (2020-2026)
10.2. Japan Blood Glucose Monitoring Market Size and Market Share By Region (2027-2033)
10.3. Kanto Region
10.4. Kinki Region
10.5. Central/ Chubu Region
10.6. Kyushu-Okinawa Region
10.7. Chugoku Region
10.8. Shikoku Region
11. Company Profile
11.1. Abbott Diabetes Care
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Roche Holding AG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. LifeScan
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Dexcom Inc
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Medtronic PLC
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Arkray Inc
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Ascensia Diabetes Care
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Agamatrix Inc
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Bionime Corporation
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Acon Laboratories Inc
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links